echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Does intensive blood pressure lowering slow down the progression of small vessel disease?

    Stroke: Does intensive blood pressure lowering slow down the progression of small vessel disease?

    • Last Update: 2021-08-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cerebral small vascular disease (SVD) accounts for 20% of ischemic strokes and is the most common cause of vascular cognitive impairment
    .


    Hypertension is a major risk factor for SVD, and lowering blood pressure (BP) is related to reducing the risk of SVD


    Blood vessel

    On the one hand, recent trials reported that strengthen blood pressure, systolic blood pressure will be set at 120-125 mm Hg, and patients with a stroke prevention in cardiovascular event reduction and secondary prevention of stroke risk reduction related
    .


    However, some people believe that excessive voltage reduction may be harmful to SVD


    Prevent cardiovascular events and stroke

    In SVD, cerebral blood flow is reduced and brain autoregulation is impaired
    .


    In the case of impaired autoregulatory function, excessive blood pressure may further reduce cerebral blood flow, accelerate white matter damage and the deterioration of cognitive function


    Autoregulation of the brain is particularly impaired in patients with severe SVD, who have fused white matter hyperplasias (WMHs) and multiple lacunar infarctions, so such patients are considered to be particularly vulnerable to excessive blood pressure reduction
    .


    The SPS3 trial found no difference in the rate of cognitive decline in intensive blood pressure reduction, but many patients have mild SVD


    The design of clinical trials to evaluate SVD interventions has always been a challenge
    .


    Neuropsychological tests that monitor cognitive changes are not sensitive to changes in the 2 to 3 year period often used in clinical trials, and changes can only be found in longer follow-ups


    The SPRINT-MRI study reported that intensive blood pressure reduction is associated with reducing the development of WMH lesions, but this is in patients with hypertension with asymptomatic SVD
    .


    Diffusion tensor imaging (DTI) is more sensitive to changes in white matter structure, and has a better correlation with cognition in SVD than in WMH volume


    In this way, Hugh S.
    Markus and others of the University of Cambridge, through the PRESERVE test, explored whether enhanced blood pressure is related to the increase in white matter damage assessed by DTI
    .

    The PRESERVE test explored whether enhanced blood pressure reduction is related to the increase in white matter damage assessed by DTI
    .


    The PRESERVE test explored whether enhanced blood pressure reduction is related to the increase in white matter damage assessed by DTI



    PRESERVE is a randomized, parallel, multi-center controlled, blinded clinical trial
    .


    A total of 111 participants with MRI confirmed symptomatic lacunar infarction and confluent white matter hyperplasia were recruited and randomly assigned to standard (systolic blood pressure=130-140 mmHg) (N=56) or enhanced ( Systolic blood pressure <125 mmHg) (N=55) blood pressure target



    The main result is the change in the mean diffusivity peak height (MDPH) of the diffusion tensor imaging white matter between baseline and 24 months
    .
    The secondary results are other magnetic resonance imaging markers and cognitive ability
    .

    The average age of the included patients was 68 years old, and 60% were men
    .
    The mean (SD) blood pressure of the standard group/intensification group was reduced by -15.
    3 (15.
    4) and -23.
    1 (22.
    04) mmHg respectively (P<0.
    001)
    .

    MDPH, there is no difference between the two groups: standard group, adjusted mean (SE) = 12.
    5×10-3 (0.
    2×10-3); enhanced group, 12.
    5×10-3 (0.
    2×10-3) , P=0.
    92
    .

    During the 24-month follow-up, the white matter microstructure of the entire population deteriorated significantly, but the cognitive ability did not decrease significantly
    .

    The important significance of this study lies in the discovery that in severe cerebral small vessel disease, enhanced blood pressure has nothing to do with the progression of white matter damage in diffusion tensor imaging or magnetic resonance imaging
    .
    In a 2-year multicenter study, multimodal DTI imaging was more sensitive to detecting changes than cognitive testing
    .

    In severe cerebral small vessel disease, enhanced blood pressure has nothing to do with the progression of white matter damage in diffusion tensor imaging or magnetic resonance imaging.
    In severe cerebral small vessel disease, enhanced blood pressure is related to white matter in diffusion tensor imaging or magnetic resonance imaging.
    The progression of the injury is irrelevant

     

    Original source:
    Markus HS, Egle M, Croall ID, et al.
    PRESERVE: Randomized Trial of Intensive Versus Standard Blood Pressure Control in Small Vessel Disease.
    Stroke.
    2021;52(8):2484-2493.
    doi:10.
    1161/STROKEAHA.
    120.
    032054

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.